Colorado Voters Approve Initiative To Legalize And Regulate Psychedelics

It was too close to call most of election night but Colorado finally confirmed that voters approved an initiative to legalize the possession of certain psychedelics and create psilocybin healing centers. Proposition 122, the Natural Medicine Health Act Initiative will immediately decriminalize psilocybin, psilocin and mescaline (not derived from peyote), ibogaine and DMT.

In addition to decriminalizing adult possession and gifting of psychedelics, voters approved the creation of regulated psilocybin therapy centers. The initiative will also provide expungement for people who have previously been convicted and served time.

Colorado will join Oregon, where Measure 109 legalized psilocybin therapy and decriminalized the personal use of other psychedelics in 2020.

Read more on the ballot’s results HERE.

New Partnership Brings Leading Psychedelic Protocol For Alcoholism Treatment To NYC

NYC-based clinics brand Nushama and clinical-stage psychedelics biotech company Awakn Life Sciences AWKNF partnered to bring Awakn’s advanced ketamine-assisted therapy treatment for AUD to Nushama’s New York clinics. 

They intend to provide sustained relief from depression, anxiety, chronic pain, addiction and trauma-induced mood disorders with high-dose IV Ketamine. 

This is the first time the KARE (Ketamine for Reduction of Alcoholic Relapse) protocol is being offered in New York City medical facilities. Nushama's co-founder and president Richard Meloff is optimistic about the new collaboration’s ability to deliver positive outcomes for patients in need of treatment: 2022 numbers show 63.3% of excessive alcohol use deaths are from chronic causes -such as Alcohol Use Disorder (AUD).

“This is truly breaking new ground in the treatment of AUD. As it is well documented, relapse rates for traditional inpatient alcohol rehab are very high. In addition, such programs are extremely …

Full story available on Benzinga.com